Cargando…

Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios

Leukemia is the most common malignancy affecting children. The morphologic analysis of bone marrow smears is an important initial step for diagnosis. Recent publications demonstrated that artificial intelligence is able to classify blood cells but a long way from clinical use. A total of 1,732 bone...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Min, Wu, Kefei, Yu, Lisha, Xu, Mengdi, Yang, Junjun, Shen, Qing, Liu, Bo, Shi, Lei, Wu, Shuang, Dong, Bin, Wang, Hansong, Yuan, Jiajun, Shen, Shuhong, Zhao, Liebin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264256/
https://www.ncbi.nlm.nih.gov/pubmed/34249819
http://dx.doi.org/10.3389/fped.2021.693676
_version_ 1783719513338937344
author Zhou, Min
Wu, Kefei
Yu, Lisha
Xu, Mengdi
Yang, Junjun
Shen, Qing
Liu, Bo
Shi, Lei
Wu, Shuang
Dong, Bin
Wang, Hansong
Yuan, Jiajun
Shen, Shuhong
Zhao, Liebin
author_facet Zhou, Min
Wu, Kefei
Yu, Lisha
Xu, Mengdi
Yang, Junjun
Shen, Qing
Liu, Bo
Shi, Lei
Wu, Shuang
Dong, Bin
Wang, Hansong
Yuan, Jiajun
Shen, Shuhong
Zhao, Liebin
author_sort Zhou, Min
collection PubMed
description Leukemia is the most common malignancy affecting children. The morphologic analysis of bone marrow smears is an important initial step for diagnosis. Recent publications demonstrated that artificial intelligence is able to classify blood cells but a long way from clinical use. A total of 1,732 bone marrow images were used for the training of a convolutional neural network (CNN). New techniques of deep learning were integrated and an end-to-end leukemia diagnosis system was developed by using raw images without pre-processing. The system creatively imitated the workflow of a hematologist by detecting and excluding uncountable and crushed cells, then classifying and counting the remain cells to make a diagnosis. The performance of the CNN in classifying WBCs achieved an accuracy of 82.93%, precision of 86.07% and F1 score of 82.02%. And the performance in diagnosing acute lymphoid leukemia achieved an accuracy of 89%, sensitivity of 86% and specificity of 95%. The system also performs well at detecting the bone marrow metastasis of lymphoma and neuroblastoma, achieving an average accuracy of 82.93%. This is the first study which included a wider variety of cell types in leukemia diagnosis, and achieved a relatively high performance in real clinical scenarios.
format Online
Article
Text
id pubmed-8264256
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82642562021-07-09 Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios Zhou, Min Wu, Kefei Yu, Lisha Xu, Mengdi Yang, Junjun Shen, Qing Liu, Bo Shi, Lei Wu, Shuang Dong, Bin Wang, Hansong Yuan, Jiajun Shen, Shuhong Zhao, Liebin Front Pediatr Pediatrics Leukemia is the most common malignancy affecting children. The morphologic analysis of bone marrow smears is an important initial step for diagnosis. Recent publications demonstrated that artificial intelligence is able to classify blood cells but a long way from clinical use. A total of 1,732 bone marrow images were used for the training of a convolutional neural network (CNN). New techniques of deep learning were integrated and an end-to-end leukemia diagnosis system was developed by using raw images without pre-processing. The system creatively imitated the workflow of a hematologist by detecting and excluding uncountable and crushed cells, then classifying and counting the remain cells to make a diagnosis. The performance of the CNN in classifying WBCs achieved an accuracy of 82.93%, precision of 86.07% and F1 score of 82.02%. And the performance in diagnosing acute lymphoid leukemia achieved an accuracy of 89%, sensitivity of 86% and specificity of 95%. The system also performs well at detecting the bone marrow metastasis of lymphoma and neuroblastoma, achieving an average accuracy of 82.93%. This is the first study which included a wider variety of cell types in leukemia diagnosis, and achieved a relatively high performance in real clinical scenarios. Frontiers Media S.A. 2021-06-24 /pmc/articles/PMC8264256/ /pubmed/34249819 http://dx.doi.org/10.3389/fped.2021.693676 Text en Copyright © 2021 Zhou, Wu, Yu, Xu, Yang, Shen, Liu, Shi, Wu, Dong, Wang, Yuan, Shen and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Zhou, Min
Wu, Kefei
Yu, Lisha
Xu, Mengdi
Yang, Junjun
Shen, Qing
Liu, Bo
Shi, Lei
Wu, Shuang
Dong, Bin
Wang, Hansong
Yuan, Jiajun
Shen, Shuhong
Zhao, Liebin
Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios
title Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios
title_full Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios
title_fullStr Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios
title_full_unstemmed Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios
title_short Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios
title_sort development and evaluation of a leukemia diagnosis system using deep learning in real clinical scenarios
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264256/
https://www.ncbi.nlm.nih.gov/pubmed/34249819
http://dx.doi.org/10.3389/fped.2021.693676
work_keys_str_mv AT zhoumin developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT wukefei developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT yulisha developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT xumengdi developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT yangjunjun developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT shenqing developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT liubo developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT shilei developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT wushuang developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT dongbin developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT wanghansong developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT yuanjiajun developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT shenshuhong developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios
AT zhaoliebin developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios